Cargando…
Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment
Enzalutamide is a nonsteroidal inhibitor of the androgen receptor (AR) signaling pathway and is used to treat patients with metastatic castration-resistant prostate cancer. However, the risk of cardiovascular-related hospitalization in patients with no contraindications for the use of enzalutamide i...
Autores principales: | Morales, Manuel, Martín-Vasallo, Pablo, Ávila, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220762/ https://www.ncbi.nlm.nih.gov/pubmed/35740293 http://dx.doi.org/10.3390/biomedicines10061271 |
Ejemplares similares
-
Glucocorticoid Receptor Gene (NR3C1) Expression in the Pathogenesis of Depression in Cancer
por: Shim, In Hee, et al.
Publicado: (2022) -
Methylation of the Glucocorticoid Receptor (NR3C1) in Placenta Is Associated with Infant Cry Acoustics
por: Sheinkopf, Stephen J., et al.
Publicado: (2016) -
NR3C1 Glucocorticoid Receptor Gene Polymorphisms Are Associated with Membranous and IgA Nephropathies
por: Pac, Michał, et al.
Publicado: (2021) -
Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
por: Chien, Chen-Yu, et al.
Publicado: (2023) -
Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors
por: Cavara, Nora A, et al.
Publicado: (2009)